Shao-xi Wu1, Ning-ru Guo. 1. Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College, Nanjing. shaoxiwu@yahoo.com
Abstract
OBJECTIVE: To investigate the effects of triptolide tablet in the treatment of patients with psoriasis vulgaris. METHODS: By an open clinical study of 103 patients with psoriasis vulgaris. Psoriasis area severity index (PASI) was measured and recorded before and after treatment for efficacy evaluation. RESULTS: Of the 103 patients, markedly effective was got in 41 (39.7%), improved in 37 (35.8%) and ineffective in 25 (24.5%), the total effective rate being 75.7%, and the adverse reaction was shown only in few patients with decreased WBC during the treatment period. CONCLUSION: Triptolide tablet is effective for the treatment of psoriasis vulgaris during the one-year follow-up.
OBJECTIVE: To investigate the effects of triptolide tablet in the treatment of patients with psoriasis vulgaris. METHODS: By an open clinical study of 103 patients with psoriasis vulgaris. Psoriasis area severity index (PASI) was measured and recorded before and after treatment for efficacy evaluation. RESULTS: Of the 103 patients, markedly effective was got in 41 (39.7%), improved in 37 (35.8%) and ineffective in 25 (24.5%), the total effective rate being 75.7%, and the adverse reaction was shown only in few patients with decreased WBC during the treatment period. CONCLUSION:Triptolide tablet is effective for the treatment of psoriasis vulgaris during the one-year follow-up.
Authors: Ian Sabroe; Lynne R Prince; Elizabeth C Jones; Malcolm J Horsburgh; Simon J Foster; Stefanie N Vogel; Steven K Dower; Moira K B Whyte Journal: J Immunol Date: 2003-05-15 Impact factor: 5.422
Authors: Bing Z Carter; Duncan H Mak; Wendy D Schober; Teresa McQueen; David Harris; Zeev Estrov; Randall L Evans; Michael Andreeff Journal: Blood Date: 2006-03-23 Impact factor: 22.113
Authors: Bing Z Carter; Duncan H Mak; Wendy D Schober; Martin F Dietrich; Clemencia Pinilla; Lyubomir T Vassilev; John C Reed; Michael Andreeff Journal: Blood Date: 2008-01-10 Impact factor: 22.113
Authors: Duncan H Mak; Wendy D Schober; Wenjing Chen; Marina Konopleva; Jorge Cortes; Hagop M Kantarjian; Michael Andreeff; Bing Z Carter Journal: Mol Cancer Ther Date: 2009-09-01 Impact factor: 6.261